152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-12, Vol.27 (suppl_9) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | suppl_9 |
| container_start_page | |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Teneggi, V. Ng, M. Tan, D.S. Subbiah, V. Weekes, C. Diermayr, V. Ethirajulu, K. Yeo, P. Chen, D. Gan, S. Blanchard, S. Nellore, R. Lee, M.A. Hill, J. Virshup, D. Madan, B. Matter, A. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw579.004 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw579_004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdw579_004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1334-67d86bbe70eb803c39d55d75476428987896fe310eb391c061b5df903bb14af43</originalsourceid><addsrcrecordid>eNotkMtOwzAURC0EEqXwAezuB2DqG7_iZVXxkip1A-vI8YMGNXYVJ6D-PUFlNdLM6CwOIffIHpEZvrIp5eRWvf-R2jwyJi7IAqUytGYCL8mCmYpTLbm4JjelfDHGlKnMgnyirHawhuPelgD4ALEbyki7RPdTbxP4PNehOHuwY5cTlHHyJ8gRnt43FKWBLoH13za54CEP0IfRlnH-Oij50HkYpz5PQ7klV9EeSrj7zyX5eJ4Rr3S7e3nbrLfUIeeCKu1r1bZBs9DWjDtuvJReS6GVqGpT69qoGDjOMzfomMJW-mgYb1sUNgq-JHjmuiGXMoTYHIeut8OpQdb8mWrOppqzqWY2xX8BavRdew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Teneggi, V. ; Ng, M. ; Tan, D.S. ; Subbiah, V. ; Weekes, C. ; Diermayr, V. ; Ethirajulu, K. ; Yeo, P. ; Chen, D. ; Gan, S. ; Blanchard, S. ; Nellore, R. ; Lee, M.A. ; Hill, J. ; Virshup, D. ; Madan, B. ; Matter, A.</creator><creatorcontrib>Teneggi, V. ; Ng, M. ; Tan, D.S. ; Subbiah, V. ; Weekes, C. ; Diermayr, V. ; Ethirajulu, K. ; Yeo, P. ; Chen, D. ; Gan, S. ; Blanchard, S. ; Nellore, R. ; Lee, M.A. ; Hill, J. ; Virshup, D. ; Madan, B. ; Matter, A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw579.004</identifier><language>eng</language><ispartof>Annals of oncology, 2016-12, Vol.27 (suppl_9)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1334-67d86bbe70eb803c39d55d75476428987896fe310eb391c061b5df903bb14af43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Teneggi, V.</creatorcontrib><creatorcontrib>Ng, M.</creatorcontrib><creatorcontrib>Tan, D.S.</creatorcontrib><creatorcontrib>Subbiah, V.</creatorcontrib><creatorcontrib>Weekes, C.</creatorcontrib><creatorcontrib>Diermayr, V.</creatorcontrib><creatorcontrib>Ethirajulu, K.</creatorcontrib><creatorcontrib>Yeo, P.</creatorcontrib><creatorcontrib>Chen, D.</creatorcontrib><creatorcontrib>Gan, S.</creatorcontrib><creatorcontrib>Blanchard, S.</creatorcontrib><creatorcontrib>Nellore, R.</creatorcontrib><creatorcontrib>Lee, M.A.</creatorcontrib><creatorcontrib>Hill, J.</creatorcontrib><creatorcontrib>Virshup, D.</creatorcontrib><creatorcontrib>Madan, B.</creatorcontrib><creatorcontrib>Matter, A.</creatorcontrib><title>152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNotkMtOwzAURC0EEqXwAezuB2DqG7_iZVXxkip1A-vI8YMGNXYVJ6D-PUFlNdLM6CwOIffIHpEZvrIp5eRWvf-R2jwyJi7IAqUytGYCL8mCmYpTLbm4JjelfDHGlKnMgnyirHawhuPelgD4ALEbyki7RPdTbxP4PNehOHuwY5cTlHHyJ8gRnt43FKWBLoH13za54CEP0IfRlnH-Oij50HkYpz5PQ7klV9EeSrj7zyX5eJ4Rr3S7e3nbrLfUIeeCKu1r1bZBs9DWjDtuvJReS6GVqGpT69qoGDjOMzfomMJW-mgYb1sUNgq-JHjmuiGXMoTYHIeut8OpQdb8mWrOppqzqWY2xX8BavRdew</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Teneggi, V.</creator><creator>Ng, M.</creator><creator>Tan, D.S.</creator><creator>Subbiah, V.</creator><creator>Weekes, C.</creator><creator>Diermayr, V.</creator><creator>Ethirajulu, K.</creator><creator>Yeo, P.</creator><creator>Chen, D.</creator><creator>Gan, S.</creator><creator>Blanchard, S.</creator><creator>Nellore, R.</creator><creator>Lee, M.A.</creator><creator>Hill, J.</creator><creator>Virshup, D.</creator><creator>Madan, B.</creator><creator>Matter, A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161201</creationdate><title>152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours</title><author>Teneggi, V. ; Ng, M. ; Tan, D.S. ; Subbiah, V. ; Weekes, C. ; Diermayr, V. ; Ethirajulu, K. ; Yeo, P. ; Chen, D. ; Gan, S. ; Blanchard, S. ; Nellore, R. ; Lee, M.A. ; Hill, J. ; Virshup, D. ; Madan, B. ; Matter, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1334-67d86bbe70eb803c39d55d75476428987896fe310eb391c061b5df903bb14af43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teneggi, V.</creatorcontrib><creatorcontrib>Ng, M.</creatorcontrib><creatorcontrib>Tan, D.S.</creatorcontrib><creatorcontrib>Subbiah, V.</creatorcontrib><creatorcontrib>Weekes, C.</creatorcontrib><creatorcontrib>Diermayr, V.</creatorcontrib><creatorcontrib>Ethirajulu, K.</creatorcontrib><creatorcontrib>Yeo, P.</creatorcontrib><creatorcontrib>Chen, D.</creatorcontrib><creatorcontrib>Gan, S.</creatorcontrib><creatorcontrib>Blanchard, S.</creatorcontrib><creatorcontrib>Nellore, R.</creatorcontrib><creatorcontrib>Lee, M.A.</creatorcontrib><creatorcontrib>Hill, J.</creatorcontrib><creatorcontrib>Virshup, D.</creatorcontrib><creatorcontrib>Madan, B.</creatorcontrib><creatorcontrib>Matter, A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teneggi, V.</au><au>Ng, M.</au><au>Tan, D.S.</au><au>Subbiah, V.</au><au>Weekes, C.</au><au>Diermayr, V.</au><au>Ethirajulu, K.</au><au>Yeo, P.</au><au>Chen, D.</au><au>Gan, S.</au><au>Blanchard, S.</au><au>Nellore, R.</au><au>Lee, M.A.</au><au>Hill, J.</au><au>Virshup, D.</au><au>Madan, B.</au><au>Matter, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours</atitle><jtitle>Annals of oncology</jtitle><date>2016-12-01</date><risdate>2016</risdate><volume>27</volume><issue>suppl_9</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><doi>10.1093/annonc/mdw579.004</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-12, Vol.27 (suppl_9) |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw579_004 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | 152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T01%3A19%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=152O%20A%20phase%201,%20first-in-human%20dose%20escalation%20study%20of%20ETC-159%20in%20advanced%20or%20metastatic%20solid%20tumours&rft.jtitle=Annals%20of%20oncology&rft.au=Teneggi,%20V.&rft.date=2016-12-01&rft.volume=27&rft.issue=suppl_9&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw579.004&rft_dat=%3Ccrossref%3E10_1093_annonc_mdw579_004%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |